Medincell
A pharmaceutical company focused on developing long-acting injectable medicines.
About
Medincell is a pharmaceutical company specializing in the development and licensing of long-acting injectable medicines based on its proprietary MedinCell® technology. This technology allows for the controlled release of active pharmaceutical ingredients over extended periods, improving patient compliance and treatment efficacy for chronic diseases. Teams look it up for Biotechnology, Pharmaceuticals, HealthTech.
Frequently asked
What does Medincell do?
Medincell is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, HealthTech. It is based in Engilbert, France and was founded in 2003. Public records show about 100 people and $48M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Medincell raised?
Medincell has raised a total of $48M in funding. The most recent round on record is Placement Privé.
Where is Medincell headquartered?
Medincell is headquartered in Engilbert, France.
When was Medincell founded?
Medincell was founded in 2003.
What industry does Medincell operate in?
Medincell operates in Biotechnology, Pharmaceuticals, HealthTech.
How many employees does Medincell have?
Medincell has approximately 100 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.